Skip to main content
JAMA Network logoLink to JAMA Network
. 2018 Jun 14;136(7):840. doi: 10.1001/jamaophthalmol.2018.2864

Error in Figure 2

PMCID: PMC8177233  PMID: 29902303

In the Original Investigation titled “Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial,”1 published online May 2, 2018, the points indicating intravitreal aflibercept injection plus sham photodynamic therapy and intravitreal aflibercept injection plus active photodynamic therapy in panel A of Figure 2 were transposed. This article was corrected online.

Reference

  • 1.Lee WK, Iida T, Ogura Y, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial [published online May 2, 2018]. JAMA Ophthalmol. doi: 10.1001/jamaophthalmol.2018.1804 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Ophthalmology are provided here courtesy of American Medical Association

RESOURCES